MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLL
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Biological and Clinical Efficacy of Shingrix in Patients With CLL
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
- Status
- COMPLETED
- Phase
- N/A
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
AGMT Austrian CLL (Chronic Lymphocytic Leukemia) Registry
- Status
- RECRUITING
- Phase
- N/A
Preliminary Assessment of [18F]BL40 in PET/CT Scans
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Hypertension and Arrhythmias in CLL Patients Treated With BTK Inhibitors
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Acalabrutinib Real World Italian obSErvational Study -ARISE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- Status
- RECRUITING
- Phase
- N/A
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PICAROS - Acalabrutinib RWE on 1L CLL in Spain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
- Status
- COMPLETED
- Phase
- NA